California State Teachers Retirement System trimmed its holdings in Humana Inc. (NYSE:HUM) by 10.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 267,182 shares of the insurance provider’s stock after selling 30,066 shares during the quarter. California State Teachers Retirement System owned about 0.18% of Humana worth $64,289,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also made changes to their positions in the company. Guardian Life Insurance Co. of America raised its stake in Humana by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares during the period. Acrospire Investment Management LLC acquired a new position in Humana during the 2nd quarter worth approximately $120,000. Independent Portfolio Consultants Inc. raised its stake in Humana by 22.1% during the 2nd quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the period. Point72 Asia Hong Kong Ltd acquired a new position in Humana during the 1st quarter worth approximately $128,000. Finally, Northwestern Mutual Wealth Management Co. raised its stake in Humana by 139.5% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after buying an additional 325 shares during the period. 95.12% of the stock is currently owned by institutional investors.
A number of research analysts recently weighed in on HUM shares. UBS AG reaffirmed a “neutral” rating and set a $250.00 price target (up from $237.00) on shares of Humana in a research note on Wednesday, August 9th. Zacks Investment Research downgraded Humana from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Cowen and Company reaffirmed a “buy” rating and set a $230.00 price target on shares of Humana in a research note on Friday, July 14th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a research note on Thursday, August 10th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $223.00 price target (up from $200.00) on shares of Humana in a research note on Thursday, August 3rd. Eleven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Humana currently has an average rating of “Buy” and an average price target of $251.60.
TRADEMARK VIOLATION WARNING: “Humana Inc. (HUM) Stake Lessened by California State Teachers Retirement System” was first posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/10/11/humana-inc-hum-stake-lessened-by-california-state-teachers-retirement-system.html.
Shares of Humana Inc. (HUM) traded up 0.58% during mid-day trading on Wednesday, hitting $241.88. The stock had a trading volume of 148,206 shares. The stock’s 50-day moving average price is $248.64 and its 200-day moving average price is $235.08. The firm has a market cap of $34.96 billion, a PE ratio of 19.67 and a beta of 0.86. Humana Inc. has a 52-week low of $163.50 and a 52-week high of $259.76.
Humana (NYSE:HUM) last released its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The firm had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same period last year, the business earned $2.30 earnings per share. On average, analysts anticipate that Humana Inc. will post $11.56 earnings per share for the current fiscal year.
The firm also recently announced a dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s payout ratio is 13.06%.
In related news, CEO Bruce D. Broussard sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $251.88, for a total value of $3,022,560.00. Following the completion of the transaction, the chief executive officer now directly owns 80,086 shares in the company, valued at approximately $20,172,061.68. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Elizabeth D. Bierbower sold 9,786 shares of the business’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the completion of the transaction, the insider now owns 18,042 shares of the company’s stock, valued at $4,672,878. The disclosure for this sale can be found here. Insiders have sold 55,595 shares of company stock valued at $14,133,706 over the last quarter. Company insiders own 0.80% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.